↓ Skip to main content

Gene Therapy for Neurological Disorders

Overview of attention for book
Cover of 'Gene Therapy for Neurological Disorders'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 Introduction to Viral Vectors and Other Delivery Methods for Gene Therapy of the Nervous System
  3. Altmetric Badge
    Chapter 2 Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors
  4. Altmetric Badge
    Chapter 3 Expression of Multiple Functional RNAs or Proteins from One Viral Vector.
  5. Altmetric Badge
    Chapter 4 Regulated Gene Therapy
  6. Altmetric Badge
    Chapter 5 Design of shRNA and miRNA for Delivery to the CNS.
  7. Altmetric Badge
    Chapter 6 Tissue-Specific Promoters in the CNS
  8. Altmetric Badge
    Chapter 7 Small-Scale Recombinant Adeno-Associated Virus Purification.
  9. Altmetric Badge
    Chapter 8 Lentivirus Production and Purification
  10. Altmetric Badge
    Chapter 9 Viral Vector Production: Adenovirus.
  11. Altmetric Badge
    Chapter 10 Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids
  12. Altmetric Badge
    Chapter 11 Altering Tropism of rAAV by Directed Evolution
  13. Altmetric Badge
    Chapter 12 Altering Entry Site Preference of Lentiviral Vectors into Neuronal Cells by Pseudotyping with Envelope Glycoproteins.
  14. Altmetric Badge
    Chapter 13 Directed Evolution of Adenoviruses
  15. Altmetric Badge
    Chapter 14 Intraparenchymal Stereotaxic Delivery of rAAV and Special Considerations in Vector Handling
  16. Altmetric Badge
    Chapter 15 MRI-Guided Delivery of Viral Vectors
  17. Altmetric Badge
    Chapter 16 Systemic Gene Therapy for Targeting the CNS
  18. Altmetric Badge
    Chapter 17 Widespread Neuronal Transduction of the Rodent CNS via Neonatal Viral Injection.
  19. Altmetric Badge
    Chapter 18 AAV-Mediated Gene Transfer to Dorsal Root Ganglion
  20. Altmetric Badge
    Chapter 19 Gene Therapy of the Peripheral Nervous System: The Enteric Nervous System
  21. Altmetric Badge
    Chapter 20 Gene Therapy of the Peripheral Nervous System: Celiac Ganglia
  22. Altmetric Badge
    Chapter 21 Convection Enhanced Delivery of Recombinant Adeno-associated Virus into the Mouse Brain
  23. Altmetric Badge
    Chapter 22 Nonviral Gene Therapy of the Nervous System: Electroporation
  24. Altmetric Badge
    Chapter 23 Non-Viral, Lipid-Mediated DNA and mRNA Gene Therapy of the Central Nervous System (CNS): Chemical-Based Transfection
  25. Altmetric Badge
    Chapter 24 Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
  26. Altmetric Badge
    Chapter 25 Gene Therapy Models of Alzheimer's Disease and Other Dementias.
  27. Altmetric Badge
    Chapter 26 Viral Vector-Based Modeling of Neurodegenerative Disorders: Parkinson's Disease.
  28. Altmetric Badge
    Chapter 27 Gene Therapy-Based Modeling of Neurodegenerative Disorders: Huntington's Disease.
  29. Altmetric Badge
    Chapter 28 Gene Therapy for the Treatment of Neurological Disorders: Amyotrophic Lateral Sclerosis.
  30. Altmetric Badge
    Chapter 29 Stereotaxic Surgical Targeting of the Nonhuman Primate Caudate and Putamen: Gene Therapy for Huntington's Disease.
  31. Altmetric Badge
    Chapter 30 Gene Therapy for the Treatment of Neurological Disorders: Metabolic Disorders
  32. Altmetric Badge
    Chapter 31 Gene Therapy for the Treatment of Neurological Disorders: Central Nervous System Neoplasms
  33. Altmetric Badge
    Chapter 32 AAV2-Neurturin for Parkinson’s Disease: What Lessons Have We Learned?
Attention for Chapter 24: Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
7 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
25 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
Ex Vivo Gene Therapy Using Human Mesenchymal Stem Cells to Deliver Growth Factors in the Skeletal Muscle of a Familial ALS Rat Model.
Chapter number 24
Book title
Gene Therapy for Neurological Disorders
Published in
Methods in molecular biology, January 2016
DOI 10.1007/978-1-4939-3271-9_24
Pubmed ID
Book ISBNs
978-1-4939-3270-2, 978-1-4939-3271-9
Authors

Suzuki, Masatoshi, Svendsen, Clive N, Masatoshi Suzuki, Clive N. Svendsen, Svendsen, Clive N.

Abstract

Therapeutic protein and molecule delivery to target sites by transplanted human stem cells holds great promise for ex vivo gene therapy. Our group has demonstrated the therapeutic benefits of ex vivo gene therapy targeting the skeletal muscles in a transgenic rat model of familial amyotrophic lateral sclerosis (ALS). We used human mesenchymal stem cells (hMSCs) and genetically modified them to release neuroprotective growth factors such as glial cell line-derived neurotrophic factor (GDNF) and vascular endothelial growth factor (VEGF). Intramuscular growth factor delivery via hMSCs can enhance neuromuscular innervation and motor neuron survival in a rat model of ALS (SOD1(G93A) transgenic rats). Here, we describe the protocol of ex vivo delivery of growth factors via lentiviral vector-mediated genetic modification of hMSCs and hMSC transplantation into the skeletal muscle of a familial ALS rat model.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 24%
Student > Ph. D. Student 6 24%
Student > Master 3 12%
Professor 1 4%
Lecturer 1 4%
Other 2 8%
Unknown 6 24%
Readers by discipline Count As %
Medicine and Dentistry 7 28%
Biochemistry, Genetics and Molecular Biology 4 16%
Neuroscience 4 16%
Agricultural and Biological Sciences 3 12%
Nursing and Health Professions 1 4%
Other 1 4%
Unknown 5 20%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 December 2015.
All research outputs
#2,236,492
of 22,834,308 outputs
Outputs from Methods in molecular biology
#383
of 13,126 outputs
Outputs of similar age
#40,731
of 393,581 outputs
Outputs of similar age from Methods in molecular biology
#53
of 1,470 outputs
Altmetric has tracked 22,834,308 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,126 research outputs from this source. They receive a mean Attention Score of 3.4. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 393,581 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 1,470 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.